Arc Institute vs Epicrispr Biotechnologies
Arc Institute vs Epicrispr Biotechnologies, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Arc Institute is on 56/100 and Epicrispr Biotechnologies on 62/100.
Where each one leads
Arc Institute
- agent readiness: 48/100 against 39/100
- domain rating: 64/100 against 40/100
- funding raised: $650M against $90.0M
Epicrispr Biotechnologies
- our overall score: 62/100 against 56/100
At a glance
| Measure | Arc Institute | Epicrispr Biotechnologies |
|---|---|---|
| What it is | A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases. | Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD). |
| Category | Biotechnology, Artificial Intelligence, Genomics, Gene Therapy | Biotechnology, Therapeutics, Rare Diseases, Epigenetics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2021 | 2020 |
| Headquarters | Palo Alto, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Arc Institute | Epicrispr Biotechnologies |
|---|---|---|
| Employees | Not published | 51 |
| Total funding | $650M | $90.0M |
| Latest round | Grant | Series C |
| LinkedIn followers | Not published | 7,025 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Arc Institute | Epicrispr Biotechnologies |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 62/100 |
| Traction | 40/100 | 57/100 |
| Team | 70/100 | 40/100 |
| Search visibility | Not published | 20/100 |
| Quality | 68/100 | 78/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (48/100) | F (39/100) |
| Domain ratingLink authority, 0-100 | 64/100 | 40/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Arc Institute | Epicrispr Biotechnologies |
|---|---|---|
| Hosting | Vercel | Not detected |
| CDN | Cloudflare | Cloudflare |
| CMS | Not detected | WordPress |
| Frameworks | Next.js, Tailwind CSS | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Not detected | Google Analytics 4 |
Arc Institute vs Epicrispr Biotechnologies: common questions
Which is better, Arc Institute or Epicrispr Biotechnologies?
On our 0-100 score Epicrispr Biotechnologies rates higher (62/100 against 56/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Arc Institute and Epicrispr Biotechnologies compare on the numbers?
Arc Institute leads on agent readiness (48/100 against 39/100), domain rating (64/100 against 40/100), funding raised ($650M against $90.0M). Epicrispr Biotechnologies leads on our overall score (62/100 against 56/100).
Read the full Arc Institute review and pricing or the Epicrispr Biotechnologies review and pricing. You can also browse other Arc Institute alternatives we track.